Stephanie Graff: Chairs kick off ESMOBreast24
Paolo Tarantino shared a post by Stephanie Graff on X, adding: .
“Impressive continuous growth for ESMO Breast, with >3000 participants and >600 submitted abstracts!”
Quoting Stephanie Graff’s post:
- 3381 Participants
- 2700 onsite in Berlin
- 620 submitted abstracts
- 6 Proffered Papers
- 17 Mini Oral presentations
- 256 Posters
- 1 Amazing Conference”
Source: Paolo Tarantino/X and Stephanie Graff/X
Dr. Paolo Tarantino, MD researcher, holds positions at both the European Institute of Oncology in Milan, Italy, and the Dana-Farber Cancer Institute in Boston, MA, Specializing in breast cancer. Currently, Dr. Tarantino is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
Stephanie Graff is the Director of the Breast Oncology Program at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University and co-leader of the Breast Cancer Translational Research Disease Group. She is an Associate Professor of Medicine at the Warren-Alpert School of Medicine.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023